Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas

JHEP Reports - Tập 3 - Trang 100326 - 2021
Sophie Chopinet1, François Cauchy1, Christian Hobeika1, Aurélie Beaufrère2, Nicolas Poté2, Olivier Farges1, Safi Dokmak1, Mohamed Bouattour3, Maxime Ronot4, Valérie Vilgrain4, Valérie Paradis2, Olivier Soubrane1
1Department of HPB and Liver Transplantation, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris and Université de Paris, Clichy, France
2Department of Pathology, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris and Université de Paris, Clichy, France
3Department of Oncology, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris and Université de Paris, Clichy, France
4Department of Radiology, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris and Université de Paris, Clichy, France

Tài liệu tham khảo

Bioulac-Sage, 2018, Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes, Clin Res Hepatol Gastroenterol Stimac, 2002, Androgenic/Anabolic steroid-induced toxic hepatitis, J Clin Gastroenterol, 35, 350, 10.1097/00004836-200210000-00013 Stoot, 2010, Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases, HPB (Oxford), 12, 509, 10.1111/j.1477-2574.2010.00222.x Bossen, 2017, Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: a nationwide population-based study, Liver Int, 37, 1042, 10.1111/liv.13423 Farges, 2011, Changing trends in malignant transformation of hepatocellular adenoma, Gut, 60, 85, 10.1136/gut.2010.222109 Gyorffy, 1989, Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use, Ann Intern Med, 110, 489, 10.7326/0003-4819-110-6-489 Dokmak, 2018, Hemorrhage of hepatocellular adenoma: a complication that can be treated by conservative management without surgery, HPB, 20, 1198, 10.1016/j.hpb.2018.06.1796 Klompenhouwer, 2017, Retrospective study on timing of resection of hepatocellular adenoma, Br J Surg, 104, 1695, 10.1002/bjs.10594 Nault, 2017, Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation, Gastroenterol, 152, 10.1053/j.gastro.2016.11.042 Nault, 2017, Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation, Gastroenterology, 152, 10.1053/j.gastro.2016.11.042 van Aalten, 2011, Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice, J Hepatol, 55, 120, 10.1016/j.jhep.2010.10.030 Nault, 2013, Hepatocellular benign tumors-from molecular classification to personalized clinical care, Gastroenterology, 144, 888, 10.1053/j.gastro.2013.02.032 Fonseca, 2013, Histological and immunohistochemical revision of hepatocellular adenomas: a learning experience, Int J Hepatol, 2013, 398308, 10.1155/2013/398308 Zucman-Rossi, 2006, Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC, Hepatology, 43, 515, 10.1002/hep.21068 Kakar, 2014, Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor, Mod Pathol, 27, 1499, 10.1038/modpathol.2014.50 Ronot, 2011, Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification, Hepatology, 53, 1182, 10.1002/hep.24147 Dokmak, 2009, A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas, Gastroenterology, 137, 1698, 10.1053/j.gastro.2009.07.061 Putra, 2020, Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon, Mod Pathol, 33, 665, 10.1038/s41379-019-0374-x Okuno, 2019, Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma?, HPB (Oxford) Nam, 2005, Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling, Hepatology, 42, 809, 10.1002/hep.20878 Nault, 2016, TERT promoter mutations in primary liver tumors, Clin Res Hepatol Gastroenterol, 40, 9, 10.1016/j.clinre.2015.07.006 Sempoux, 2014, Malignant transformation of hepatocellular adenoma, Hepat Oncol, 1, 421, 10.2217/hep.14.14 Calderaro, 2017, Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification, J Hepatol, 67, 727, 10.1016/j.jhep.2017.05.014 Zulfiqar, 2020, Hepatocellular adenomas: understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach, J Magn Reson Imag, 51, 1630, 10.1002/jmri.26902 Bise, 2018, New MRI features improve subtype classification of hepatocellular adenoma, Eur Radiol Reizine, 2019, Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping, Eur Radiol, 29, 3791, 10.1007/s00330-019-06150-7 Laumonier, 2008, Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification, Hepatology, 48, 808, 10.1002/hep.22417 Lewin, 2006, Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings, Radiology, 241, 433, 10.1148/radiol.2412051243